Monthly Archives: April 2016

Apheresis Equipment Market – In Which Direction will Tightening Grip of Regulators Steer Growth?

The global market for apheresis equipment is projected to stand at a valuation of US$2.3 bn by 2018, according to Transparency Market Research (TMR). The market intelligence firm also states that the global apheresis equipment market is expected to log a compounded annual growth rate (CAGR) of 11.3% between 2012 and 2013. Although these numbers might seem encouraging, regulators are watching this space more closely than ever before; the market’s growth is certainly not devoid of challenges.

Get Free Sample Research Report: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=871

While on one hand growth will occur as a result of a spike in demand for plasma products and plasma itself, the risks associated with the procedure are likely to pose an obstacle to the apheresis equipment market’s growth.

Regulators in the U.S. are Proposing to Classify Apheresis Systems as Class 2 Medical Devices

In a recent development on the regulatory front, a panel of advisers to the United States Food and Drug Administration (FDA) have stressed on more regulatory scrutiny for medical devices that use centrifugal force on whole blood so as to separate blood components such as plasma and then pump that blood back into the patient. The FDA, in February 2016, convened the Gastroenterology and Urology Devices Panel, which functions under the aegis of the Medical Devices Advisory Committee, to receive inputs on how such devices should be regulated.

The fact that this development is occurring in the United States, one of the largest markets worldwide for apheresis equipment will have some impact on the global market too. In the United States, as many as 17 types of centrifuge-based apheresis systems for therapeutic purposes have received a stamp of approval and are on the market, says a report on the Medscape website. However, these devices have not been assigned to any of the classes created by medical device regulatory authorities via a 1976 law.

The American Society for Apheresis terms apheresis as being an effective first-line therapy for a range of diseases such as Guillain-Barré syndrome, severe cryoglobulinemia, myasthenia gravis, and fulminant Wilson disease, among others. In several other illnesses, apheresis is used as a second-line treatment. However, of the 1447 reports that were submitted to the agency between 2010 and 2015, 20 reports of deaths were also included.

The FDA has noted that many of the aforementioned diseases have a high rate of morbidity, which could also be attributable to the many deaths and adverse events associated with its examination of the Manufacturer and User Facility Device Experience database for apheresis equipment.

Going forward, the agency is proposing to classify apheresis systems as class 2 medical devices. This class includes devices that pose an intermediate degree of risk and such devices are required to undergo a 510K premarket clearance. Also on the cards in the United States is more detailed information on the labels of apheresis equipment and systems. However, a final decision on this front is awaited.

Where do the Growth Opportunities Lie in the Global Apheresis Equipment Market?

The growing interest in using apheresis therapy during anti-aging treatments is expected to have a positive impact on the market’s overall growth. Plasma therapy, for instance, has been endorsed by numerous celebrities and is on course to becoming a mainstream anti-aging treatment. This opens a new window of opportunity for companies in the global apheresis equipment market.

Full Research Report on Global Apheresis Equipment Market:
http://www.transparencymarketresearch.com/apheresis-equipment.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Advertisements

Need for Improved Patient-Physician Coordination to Boost Global Medical Practice Management Software Market

Medical practice management software (PMS) assists in managing a healthcare business, starting from the scheduling of patients to the generation of periodic reports. Therefore, selecting the appropriate medical practice management system is crucial in any medical practice. The onus of selecting the practice management software and managing it lies with the IT manager in any healthcare providing institution.

Get Free Sample Research Report: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1155

The medical practice management software market helps in integration of electronic health records (EHR), in providing interoperability solutions, and assists in the overall practice management process. The software provides solutions on single database platforms, on multi-tenant SaaS deployed on-premise, and even on cloud platforms. The prime factors which invigorate this market are the need for high return on investment, various funding and grants provided by the government, need for better patient-physician coordination, and increase in patient awareness and better health. Choosing the right PMS is a critical task in healthcare management because its functionality greatly determines the overall productivity of the institution in which it is installed. The major challenge faced by PMS users is the time required to completely implement the system in the institution.

The market is set to grow drastically in North America due to government policies in the U.S, especially due to ‘Obamacare’, which makes it compulsory for health care providers to use such software. Europe is the second largest share holder in the global market. With the improvement in the economies of developing countries, Asia is also set to generate huge demand. Some of the major players in medical practice software are Sage Group, NextGen Healthcare, AthenaHealth, eClinicalWorks, MediTouch, and McKesson.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Full Research Report on Global Medical Practice Management Software Market:
http://www.transparencymarketresearch.com/medical-practice-management-software.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
http://marketsresearchreports.blogspot.com/